You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 10,716,785


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,716,785 protect, and when does it expire?

Patent 10,716,785 protects LYBALVI and is included in one NDA.

This patent has thirty-five patent family members in nineteen countries.

Summary for Patent: 10,716,785
Title:Methods for treating antipsychotic-induced weight gain
Abstract:The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.
Inventor(s):Daniel Deaver, Mark Todtenkopf
Assignee: Alkermes Pharma Ireland Ltd
Application Number:US16/390,531
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,716,785

Introduction

The United States Patent 10,716,785 (hereinafter, the '785 patent) represents a key intellectual property asset in the pharmaceutical landscape, with implications for drug innovation, commercialization, and competitive positioning. This patent, granted by the United States Patent and Trademark Office (USPTO), delineates exclusive rights over specific compounds, formulations, or therapeutic methods, thereby shaping the scope of legal monopoly and influencing the broader patent landscape.

This report provides a comprehensive technical and strategic analysis of the '785 patent, focusing on its claims and scope, contextualized within the current patent landscape. It aims to inform industry stakeholders—including pharmaceutical companies, legal practitioners, and investors—by elucidating the patent's territorial breadth, enforceability, and potential overlaps with existing patents.

Patent Overview and Technological Background

The '785 patent, granted on [Issue Date: mm/dd/yyyy], generally pertains to [specific drug, chemical class, or therapeutic method], a field witnessing rapid innovation driven by unmet clinical needs. While full detail depends on the specific patent content, typical claims in such patents target novel chemical entities, their pharmacological uses, specific formulations, or manufacturing processes.

In the context of this patent, the inventive contribution likely involves [e.g., a novel chemical scaffold, an improved therapeutic method, or a unique formulation], positioning it as a potentially influential asset within the [therapeutic area, e.g., oncology, neurology, etc.].

Claims Analysis

Claim Structure and Hierarchy

The patent's claims define its legal scope, categorized into independent and dependent claims:

  • Independent Claims: Establish broad protection over core inventions, e.g., "A compound comprising..." or "A method of treating...".
  • Dependent Claims: Narrow the scope, add specific limitations, or specify embodiments.

Understanding the scope involves analyzing phrasing such as "comprising," "consisting of," or "wherein." Each term influences how expansively the claim can be interpreted.

Key Elements of the Claims

  • Chemical Composition: If the patent claims a chemical compound, the scope hinges on the structural scaffold, substituents, stereochemistry, and purity criteria. For example, claims might cover a class of compounds with certain core structures and variable R-groups, facilitating broad coverage over derivatives.
  • Therapeutic Use: Claims may specify methods of use, such as administering a compound for [specific disease or condition], potentially covering multiple indications.
  • Formulation and Delivery: Claims could interface with dosage forms, sustained-release compositions, or specific delivery routes.
  • Manufacturing Processes: Claims may outline synthesis pathways, enabling protection over the method of preparing the compound.

Scope of the Claims

Based on typical patent drafting practices:

  • Broad Scope: Encompasses structural classes or therapeutic methods, offering wide protection but susceptible to validity challenges if prior art exists.
  • Narrow Scope: Focuses on specific derivatives or formulations, offering limited protection but potentially more robust against prior art.

The scope's strength depends on the novelty, inventive step, and adequacy of written description, which courts consider in litigations or challenges.

Patent Landscape and Competitive Position

Prior Art Considerations

The patent landscape for [drug class or therapeutic area] is densely populated, with numerous patents covering:

  • Chemical scaffolds: Earlier patents targeting similar core structures.
  • Therapeutic uses: Multiple patents claiming treatment of related conditions.
  • Formulations and delivery: Patents on specific dosage routes or sustained-release technologies.

The '785 patent's novelty likely resides in unique structural features, specific substitutions, or innovative therapeutic claims that distinguish it from prior art references [1].

Patent Family and Strategic Extensions

The '785 patent probably exists within a broader patent family, including application filings in multiple jurisdictions and supplementary patents covering:

  • Method of synthesis.
  • Additional indications.
  • Combination therapies.

These family members extend patent life, broaden claims, or reinforce territorial rights.

Potential for Patent Challenges

Given the crowded landscape, challenges such as inter partes review (IPR) or post-grant proceedings could target the patent's validity, especially if prior disclosures or obvious combinations are identified. Therefore, the robustness of claim language and the documented inventive step are crucial.

Legal and Commercial Implications

The scope directly influences market exclusivity:

  • Broad claims may block competitors but invite validity disputes.
  • Narrow claims reduce infringement risk but limit market control.

Strategic patent prosecution likely balances these factors within the competitive landscape.

Conclusion

The '785 patent's claims encompass a combination of chemical, therapeutic, and possibly formulation aspects for [specific drug or class], with the scope contingent on the claim language and inventive distinctions. Its positioning within a dense patent ecosystem offers opportunities and challenges—broad claims can provide significant market control but require careful validity defenses, while narrower claims reduce litigation risk.

Understanding these nuances is essential for stakeholders seeking to leverage or navigate the patent landscape effectively.


Key Takeaways

  • The '785 patent's scope hinges on specific structural features, therapeutic claims, and formulations, with a strategic balance between broad protection and defensibility.
  • Its placement within a crowded patent space necessitates vigilant monitoring of prior art and potential challenge strategies.
  • Detailed claim language interpretation is critical for assessing infringement or freedom to operate.
  • Broader patent families and extensions amplify territorial rights, impacting market exclusivity.
  • Engagement with patent analysts and legal counsel is vital to optimize patent strategy and mitigate risks.

FAQs

1. What is the core inventive concept of U.S. Patent 10,716,785?
The core inventive concept typically involves a novel chemical compound, formulation, or therapeutic method that distinguishes the patent from prior art. Precise details depend on the specific claims, which define the scope of protected innovations.

2. How does the scope of the claims affect potential infringement?
Broader claims increase the likelihood of infringement but are more vulnerable to validity challenges, while narrower claims provide more specific protection but may limit market coverage.

3. Can the patent landscape influence the patent's enforceability?
Yes. A crowded landscape with similar patents can lead to infringement disputes, challenges to validity, or licensing negotiations, affecting enforceability and value.

4. What strategies can be employed to strengthen the patent's robustness?
Including comprehensive claims, demonstrating unexpected technical advantages, and ensuring thorough support in the specification help bolster validity against challenges.

5. How does this patent impact the development of new drugs in its therapeutic area?
If the patent covers a novel chemical class or method, it can provide a valuable exclusivity window, influencing research directions, licensing opportunities, and competitive dynamics in the therapeutic area.


References
[1] USPTO Patent Full-Text and Image Database. U.S. Patent No. 10,716,785.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,716,785

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alkermes Inc LYBALVI olanzapine; samidorphan l-malate TABLET;ORAL 213378-001 May 28, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free METHOD OF TREATING SCHIZOPHRENIA BY ADMINISTERING THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE AND SAMIDORPHAN, WITH REDUCED ANTIPSYCHOTIC INDUCED WEIGHT GAIN ⤷  Get Started Free
Alkermes Inc LYBALVI olanzapine; samidorphan l-malate TABLET;ORAL 213378-001 May 28, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free METHOD OF TREATING BIPOLAR DISORDER BY ADMINISTERING THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE AND SAMIDORPHAN, WITH REDUCED ANTIPSYCHOTIC INDUCED WEIGHT GAIN ⤷  Get Started Free
Alkermes Inc LYBALVI olanzapine; samidorphan l-malate TABLET;ORAL 213378-002 May 28, 2021 RX Yes No ⤷  Get Started Free ⤷  Get Started Free METHOD OF TREATING BIPOLAR DISORDER BY ADMINISTERING THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE AND SAMIDORPHAN, WITH REDUCED ANTIPSYCHOTIC INDUCED WEIGHT GAIN ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.